New tool aims to predict dangerous pregnancy outcomes in rare blood disorder

NCT ID NCT07101770

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to create a prediction tool for pregnant women with aplastic anemia, a rare blood disorder that raises risks of bleeding, infection, and complications like preterm birth. Researchers will follow 300 women to identify factors that lead to poor outcomes for mother and baby. The goal is to help doctors manage these high-risk pregnancies earlier and more effectively.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APLASTIC ANEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Peking University People's Hospital

    RECRUITING

    Beijing, 100044, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.